2020ACS指南:普通风险人群的宫颈癌筛查

2020-07-30 美国癌症学会 CA Cancer J Clin. 2020;10.3322/caac.21628.

多年来,随着对疾病自然史,对高危人类乳头瘤病毒(hrHPV)类型感染的因果关系的了解以及不断变化的筛查测试技术的影响,对宫颈癌筛查的建议不断发展。

中文标题:

2020ACS指南:普通风险人群的宫颈癌筛查

英文标题:

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

发布机构:

美国癌症学会

发布日期:

2020-07-30

简要介绍:

多年来,随着对疾病自然史,对高危人类乳头瘤病毒(hrHPV)类型感染的因果关系的了解以及不断变化的筛查测试技术的影响,对宫颈癌筛查的建议不断发展。重大变化包括开始筛查的年龄较大,放弃对第一次阴道性交的提及作为早期筛查的因素,延长了筛查间隔,以及在筛查方案中纳入了HPV检测。美国癌症协会(ACS)指南的最新更新是在2012年,是ACS,美国阴道镜和宫颈病理学会(ASCCP)和美国临床病理学会之间的联合指南。

相关资料下载:
[AttachmentFileName(sort=1, fileName=caac.21628.pdf)] GetToolGuiderByIdResponse(projectId=1, id=553b81c0019a6332, title=2020ACS指南:普通风险人群的宫颈癌筛查, enTitle=Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society, guiderFrom=CA Cancer J Clin. 2020;10.3322/caac.21628., authorId=0, author=, summary=多年来,随着对疾病自然史,对高危人类乳头瘤病毒(hrHPV)类型感染的因果关系的了解以及不断变化的筛查测试技术的影响,对宫颈癌筛查的建议不断发展。, cover=, journalId=0, articlesId=null, associationId=3, associationName=美国癌症学会, associationIntro=美国癌症学会(ACS,American Cancer Society)是全国性的以社区为基础的志愿健康组织,致力于消灭癌症。总部设在亚特兰大,包括12个分部,900多个当地办事处,以及5100多个社区。, copyright=0, guiderPublishedTime=Thu Jul 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p><span style="color: #1c1d1e;">多年来,随着对疾病自然史,对高危人类乳头瘤病毒(hrHPV)类型感染的因果关系的了解以及不断变化的筛查测试技术的影响,对宫颈癌筛查的建议不断发展。</span><span style="color: #1c1d1e;">重大变化包括开始筛查的年龄较大,放弃对第一次阴道性交的提及作为早期筛查的因素,延长了筛查间隔,以及在筛查方案中纳入了HPV检测。</span><span style="color: #1c1d1e;">美国癌症协会(ACS)指南的最新更新是在2012年,是ACS,美国阴道镜和宫颈病理学会(ASCCP)和美国临床病理学会之间的联合指南。</span></p>, tagList=[], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21053, categoryName=梅斯医学-宫颈癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6744, appHits=331, showAppHits=0, pcHits=2203, showPcHits=6412, likes=5, shares=13, comments=16, approvalStatus=1, publishedTime=Thu Aug 06 14:51:51 CST 2020, publishedTimeString=2020-07-30, pcVisible=1, appVisible=1, editorId=5114811, editor=gushiqian, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=gushiqian, createdTime=Thu Aug 06 14:51:46 CST 2020, updatedBy=5114811, updatedName=gushiqian, updatedTime=Fri Jan 05 20:33:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=caac.21628.pdf)])
caac.21628.pdf
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=996245, encodeId=fb1c99624515, content=指导临床很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e32570990, createdName=12582e2em19暂无昵称, createdTime=Sun Jul 04 22:43:27 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977718, encodeId=33019e7718fb, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/c582e34dffd844118ae8b268544ea803/7d01ec9d114d4ffcade0890edec85110.jpg, createdBy=95475535653, createdName=宝宝呼啦, createdTime=Mon Jun 28 21:50:24 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970528, encodeId=95039e0528e0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05735512329, createdName=ms2000001907619075, createdTime=Thu Jun 03 10:35:28 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962143, encodeId=e26f96214381, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e5479757, createdName=ms1000000173390848, createdTime=Sat May 01 17:43:15 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948396, encodeId=12ca94839633, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff65469331, createdName=ms3000001168991256, createdTime=Mon Mar 15 16:18:56 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-07-04 12582e2em19暂无昵称

    指导临床很有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=996245, encodeId=fb1c99624515, content=指导临床很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e32570990, createdName=12582e2em19暂无昵称, createdTime=Sun Jul 04 22:43:27 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977718, encodeId=33019e7718fb, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/c582e34dffd844118ae8b268544ea803/7d01ec9d114d4ffcade0890edec85110.jpg, createdBy=95475535653, createdName=宝宝呼啦, createdTime=Mon Jun 28 21:50:24 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970528, encodeId=95039e0528e0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05735512329, createdName=ms2000001907619075, createdTime=Thu Jun 03 10:35:28 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962143, encodeId=e26f96214381, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e5479757, createdName=ms1000000173390848, createdTime=Sat May 01 17:43:15 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948396, encodeId=12ca94839633, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff65469331, createdName=ms3000001168991256, createdTime=Mon Mar 15 16:18:56 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-06-28 宝宝呼啦

    很有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=996245, encodeId=fb1c99624515, content=指导临床很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e32570990, createdName=12582e2em19暂无昵称, createdTime=Sun Jul 04 22:43:27 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977718, encodeId=33019e7718fb, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/c582e34dffd844118ae8b268544ea803/7d01ec9d114d4ffcade0890edec85110.jpg, createdBy=95475535653, createdName=宝宝呼啦, createdTime=Mon Jun 28 21:50:24 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970528, encodeId=95039e0528e0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05735512329, createdName=ms2000001907619075, createdTime=Thu Jun 03 10:35:28 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962143, encodeId=e26f96214381, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e5479757, createdName=ms1000000173390848, createdTime=Sat May 01 17:43:15 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948396, encodeId=12ca94839633, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff65469331, createdName=ms3000001168991256, createdTime=Mon Mar 15 16:18:56 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-06-03 ms2000001907619075

    感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=996245, encodeId=fb1c99624515, content=指导临床很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e32570990, createdName=12582e2em19暂无昵称, createdTime=Sun Jul 04 22:43:27 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977718, encodeId=33019e7718fb, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/c582e34dffd844118ae8b268544ea803/7d01ec9d114d4ffcade0890edec85110.jpg, createdBy=95475535653, createdName=宝宝呼啦, createdTime=Mon Jun 28 21:50:24 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970528, encodeId=95039e0528e0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05735512329, createdName=ms2000001907619075, createdTime=Thu Jun 03 10:35:28 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962143, encodeId=e26f96214381, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e5479757, createdName=ms1000000173390848, createdTime=Sat May 01 17:43:15 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948396, encodeId=12ca94839633, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff65469331, createdName=ms3000001168991256, createdTime=Mon Mar 15 16:18:56 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-05-01 ms1000000173390848

    有收获

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=996245, encodeId=fb1c99624515, content=指导临床很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e32570990, createdName=12582e2em19暂无昵称, createdTime=Sun Jul 04 22:43:27 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977718, encodeId=33019e7718fb, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/c582e34dffd844118ae8b268544ea803/7d01ec9d114d4ffcade0890edec85110.jpg, createdBy=95475535653, createdName=宝宝呼啦, createdTime=Mon Jun 28 21:50:24 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970528, encodeId=95039e0528e0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05735512329, createdName=ms2000001907619075, createdTime=Thu Jun 03 10:35:28 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962143, encodeId=e26f96214381, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e5479757, createdName=ms1000000173390848, createdTime=Sat May 01 17:43:15 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948396, encodeId=12ca94839633, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff65469331, createdName=ms3000001168991256, createdTime=Mon Mar 15 16:18:56 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-03-15 ms3000001168991256

    感谢分享

    0